The store will not work correctly when cookies are disabled.
(R)-gamma-(2-cyanobenzyl)-L-proline Hydrochloride
ID: ALA4101466
Cas Number: 1049743-86-3
PubChem CID: 2762033
Max Phase: Preclinical
Molecular Formula: C13H15ClN2O2
Molecular Weight: 230.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.N#Cc1ccccc1C[C@H]1CN[C@H](C(=O)O)C1
Standard InChI: InChI=1S/C13H14N2O2.ClH/c14-7-11-4-2-1-3-10(11)5-9-6-12(13(16)17)15-8-9;/h1-4,9,12,15H,5-6,8H2,(H,16,17);1H/t9-,12+;/m1./s1
Standard InChI Key: CCANPXGPMAXDIM-KATIXKQHSA-N
Molfile:
RDKit 2D
18 18 0 0 0 0 0 0 0 0999 V2000
10.7839 -11.9036 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.7945 -13.4720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4650 -13.9586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1295 -13.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8647 -12.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0421 -12.6843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9121 -13.7102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0896 -14.5117 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5212 -13.1548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5560 -12.0243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9496 -11.2983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7754 -11.2808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1690 -10.5558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7372 -9.8510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9075 -9.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5176 -10.6012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6987 -10.6270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8784 -10.6523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 2 1 0
4 7 1 1
7 8 2 0
7 9 1 0
6 10 1 6
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 3 0
16 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 230.27 | Molecular Weight (Monoisotopic): 230.1055 | AlogP: 1.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 73.12 | Molecular Species: ZWITTERION | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.01 | CX Basic pKa: 11.42 | CX LogP: -0.77 | CX LogD: -0.77 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.82 | Np Likeness Score: -0.16 |
References
1. (2014) D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders, |